analysis for NCT00514683 [clinicaltrials_resource:NCT00514683/analysis/0fa13fb3da417221f6cf8382c98d4d26]
analysis [clinicaltrials_vocabulary:analysis]
analysis for NCT00514683 [clinicaltrials_resource:NCT00514683/analysis/0fa13fb3da417221f6cf8382c98d4d26]
Bio2RDF identifier
NCT00514683/analysis/0fa13fb3da417221f6cf8382c98d4d26
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... a13fb3da417221f6cf8382c98d4d26
ci lower limit [clinicaltrials_vocabulary:ci-lower-limit]
ci n sides [clinicaltrials_vocabulary:ci-n-sides]
ci percent [clinicaltrials_vocabulary:ci-percent]
ci upper limit [clinicaltrials_vocabulary:ci-upper-limit]
4.960000038146973e+0
dispersion type [clinicaltrials_vocabulary:dispersion-type]
Standard Error of the Mean
dispersion value [clinicaltrials_vocabulary:dispersion-value]
2.490000009536743e+0
estimate desc [clinicaltrials_vocabulary:estimate-desc]
Mean difference to placebo is calculated. Negative change indicates worsening.
method [clinicaltrials_vocabulary:method]
method desc [clinicaltrials_vocabulary:method-desc]
ANCOVA with fixed terms for treatment, baseline, region.
non inferiority [clinicaltrials_vocabulary:non-inferiority]
p value [clinicaltrials_vocabulary:p-value]
9.811000227928162e-1
param type [clinicaltrials_vocabulary:param-type]
Mean Difference (Final Values)
param value [clinicaltrials_vocabulary:param-value]
5.999999865889549e-2
identifier
clinicaltrials_resource:NCT00514683/analysis/0fa13fb3da417221f6cf8382c98d4d26
title
analysis for NCT00514683
@en
type
label
analysis for NCT00514683 [clin ...... 13fb3da417221f6cf8382c98d4d26]
@en